Common Stock, par value $0.001 per share
- Symbol
- CABR
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 5.07 · 8-K
Caring Brands, Inc.
CABRNASDAQEQUITYCurrent
Submission of Matters to a Vote of Security Holders
Item Submission 5.07 of Matters to a Vote of Security Holders. On July 9, 2026, Caring Brands, Inc. (the “Company”) held a Special Meeting of Stockholders (the “Special Meeting”). Each proposal presented at the Special Meeting is described in detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on May 27, 2026 (the “Proxy Statement”).…
Company context
We are a wellness consumer products company. We offer several over-the-counter (OTC) and cosmetic consumer products. Our product pipeline includes a diverse range of products, such as hair loss treatments, eczema and psoriasis treatments, vitiligo solutions, a jellyfish sting protective suncare line, and women’s sexual wellness products, catering to diverse health and wellness needs. Our method of operation ensures that (1) the mechanism of action of all products is established, (2) efficacy is determined through controlled clinical trials, (3) products are protected by issued and filed patents, and (4) products have acceptable commercial stability.
Current securities
Registered securities in this filing
Caring Brands, Inc. · 8-K · Filed 2026-07-14
Disclosure sections
Item 5.07Item 5.07 - Submission of Matters to Vote
Item Submission
5.07 of Matters to a Vote of Security Holders.
On
July 9, 2026, Caring Brands, Inc. (the “Company”) held a Special Meeting of Stockholders (the “Special Meeting”).
Each proposal presented at the Special Meeting is described in detail in the Company’s definitive proxy statement filed with the
Securities and Exchange Commission on May 27, 2026 (the “Proxy Statement”).
As
of the close of business on May 14, 2026, the record date for the Special Meeting, there were 9,091,506 shares of the Company’s
common stock, par value $0.001 per share (the “Common Stock”), issued and outstanding and entitled to vote.
At
the Special Meeting, holders of 5,617,697 shares of Common Stock, representing approximately 61.79% of the shares entitled to vote, were
present in person or represented by a proxy, constituting a quorum. The matters voted upon at the Special Meeting, and the numbers of
votes cast for or against, as well as the number of abstentions and broker non-votes, as to each matter, are set forth below.
Proposal
No. 1: Approval of the Additional Investment Right Proposal
For Against Abstain Broker Non-Vote
────────────────────────────────────────────────────────────
4,457,375 155,999 1,000 1,003,323
The
proposal was approved by the requisite vote.
Proposal
No. 2: Approval of the Share Issuance Proposal
For Against Abstain Broker Non-Vote
────────────────────────────────────────────────────────────
4,456,776 156,598 1,000 1,003,323
The
proposal was approved by the requisite vote.
Proposal
No. 3: Approval of the Increase in the Number of Authorized Shares of Common Stock Proposal
For Against Abstain Broker Non-Vote
────────────────────────────────────────────────────────────
5,118,645 498,052 1,000 0
The
proposal was approved by the requisite vote.
The
results reported above are final voting results. No other matters were considered or voted upon at the meeting, except a proposal to
adjourn the Special Meeting to a later date, if necessary, to permit further solicitation and vote proxies in the event there were not
sufficient votes in favor of the listed proposals. Based upon the voting results, the latter was not applicable.